Bevacizumab and Irinotecan to Treat Brain Tumors

NCT00393094 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

31

Enrollment

NIH

Sponsor class

Stopped Terminated due to the limitations of accrual.

Conditions

High-Grade Gliomas

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Irinotecan hydrochloride

Sponsor

National Cancer Institute (NCI)